BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
KLK3
,
calcium channel activity
,
Influenza
,
Leukocyte
,
Personalized medicine
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
agent combination
Summary
General Info
Curated Studies
Most Correlated Studies
Drug target sets for approved compounds
Broad Connectivity Map (CMAP 2.0) compound database
Liver tissues from rats after treatment with different compounds
Retinoic acid treatment of stellate cells - time course
Colorectal cancer biopsies collected prospectively from therapy responders and non-responders
Explore Curated Studies Results
Literature
Most Relevant Literature
MGAE-DC: Predicting the synergistic effects of drug combinations through multi-channel graph autoenc…
Predicting Drug Synergy and Discovering New Drug Combinations Based on a Graph Autoencoder and Convo…
Predicting cell line-specific synergistic drug combinations through a relational graph convolutional…
Implantable Microdevices Identify Microenvironment-Modulating Drug Combinations.
MPFFPSDC: A multi-pooling feature fusion model for predicting synergistic drug combinations.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Study of Ambrisentan With Antifibrotic Agent Combination Therapy in Diffuse Systemic Sclerosis
A Study of FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies…
DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Rel…
PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumor…
PF-07104091 as a Single Agent and in Combination Therapy
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ